Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β₂-agonists in patients with atopic asthma

References

• HolgateSTInnate and adaptive immune responses in asthmaNat Med20121867368322561831
   PubMed Web of Science ®Google Scholar
• Global Initiative for AsthmaGlobal Strategy for Asthma Management and PreventionBethesda (MD)GINA2016
   Google Scholar
• O’ByrnePMNajiNGauvreauGMSevere asthma: future treatmentsClin Exp Allergy20124270671122515391
   PubMed Web of Science ®Google Scholar
• SchuligoiRSturmELuschnigPCRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseasesPharmacology20108537238220559016
   PubMed Web of Science ®Google Scholar
• HiraiHTanakaKYoshieOProstaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2J Exp Med200119325526111208866
   PubMed Web of Science ®Google Scholar
• MjösbergJMTrifariSCrellinNKHuman IL-25- and IL-33- responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161Nat Immunol2011121055106221909091
   PubMed Web of Science ®Google Scholar
• KrauseAZisowskyJStrasserDSPharmacokinetic/pharmacodynamic modelling of receptor internalization with CRTH2 antagonists to optimize dose selectionClin Pharmacokinet20165581382126692193
   PubMed Web of Science ®Google Scholar
• HallIPFowlerAFGuptaAEfficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatmentPulm Pharmacol Ther201532374425861737
   PubMed Web of Science ®Google Scholar
• XueLSalimiMPanseIProstaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cellsJ Allergy Clin Immunol20141331184119424388011
   PubMed Web of Science ®Google Scholar
• ChangYJDeKruyffRHUmetsuDTThe role of type 2 innate lymphoid cells in asthmaJ Leukoc Biol20139493394023801654
   PubMed Web of Science ®Google Scholar
• BalzarSFajtMLComhairSAMast cell phenotype, location, and activation in severe asthma: data from the Severe Asthma Research ProgramAm J Respir Crit Care Med2011183329930920813890
   PubMed Web of Science ®Google Scholar
• FajtMLGelhausSLFreemanBProstaglandin D2 pathway upregulation: relation to asthma severity, control, and TH2 inflammationJ Allergy Clin Immunol20131311504151223506843
   PubMed Web of Science ®Google Scholar
• UllerLMathiesenJMAlenmyrLAntagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammationRespir Res200781617328802
   PubMed Web of Science ®Google Scholar
• LukacsNWBerlinAAFranz-BaconKCRTH2 antagonism significantly ameliorates airway hyperreactivity and downregulates inflammation-induced genes in a mouse model of airway inflammationAm J Physiol Lung Cell Mol Physiol2008295L767L77918757520
   PubMed Web of Science ®Google Scholar
• StebbinsKJBroadheadARCorreaLDTherapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammationEur J Pharmacol201063814214920447387
   PubMed Web of Science ®Google Scholar
• SinghDCaddenPHunterMInhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459Eur Respir J201341465222496329
   PubMed Web of Science ®Google Scholar
• BarnesNPavordIChuchalinAA randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthmaClin Exp Allergy201242384821762224
   PubMed Web of Science ®Google Scholar
• LukerTBonnertRSchmidtJSubstituted indole-1-acetic acids as potent and selective CRTH2 antagonists: discovery of AZD1981Bioorg Med Chem Lett2011216288629221944852
   PubMed Web of Science ®Google Scholar
• GonemSBerairRSingapuriAFevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trialLancet Respir Med2016469970727503237
   PubMed Web of Science ®Google Scholar
• ErpenbeckVJPopovTAMillerDThe oral CRTH2 antagonist QAW039 (fevipiprant): a phase II study in uncontrolled allergic asthmaPulm Pharmacol Ther201639546327354118
   PubMed Web of Science ®Google Scholar
• PettipherRHunterMGPerkinsCMHeightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459Allergy2014691223123224866478
   PubMed Web of Science ®Google Scholar
• SchmidtJBFAkamEBiochemical and pharmacological characterization of AZD1981, an orally available selective DP2 antagonist in clinical development for asthmaBr J Pharmacol201316816261638
   Web of Science ®Google Scholar
• KunaPBjermerLTornlingGTwo phase II randomized trials on the CR Th2 antagonist AZD1981 in adults with asthmaDrug Des Devel Ther20161027592770
   PubMed Web of Science ®Google Scholar
• QuanjerPHTammelingGJCotesJEPedersenOFPeslinRYernaultJCLung volumes and forced ventilatory flowsEur Respir J19936Suppl 16540
   PubMed Web of Science ®Google Scholar
• MerrettJMerrettTGPhadiatop: a novel IgE antibody screening testClin Allergy1987174094163315300
   PubMedGoogle Scholar
• JuniperEFO’ByrnePMRobertsJNMeasuring asthma control in group studies: do we need airway calibre and rescue β2-agonist use?Respir Med20019531932311392570
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J20052631933816055882
   PubMed Web of Science ®Google Scholar
• JuniperEFBuistASCoxFMFerriePJKingDRValidation of a standardized version of the Asthma Quality of Life QuestionnaireChest19991151265127010334138
   PubMed Web of Science ®Google Scholar
• CorrenJLemanskeRFHananiaNALebrikizumab treatment in adults with asthmaN Engl J Med20113651088109821812663
   PubMed Web of Science ®Google Scholar
• PettipherRHanselTTArmerRAntagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseasesNat Rev Drug Discov2007631332517396136
   PubMed Web of Science ®Google Scholar
• BusseWWWenzelSEMeltzerEOSafety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patientsJ Allergy Clin Immunol201313133934523174659
   PubMed Web of Science ®Google Scholar
• HallISarnoMDisseBEfficacy and safety of BI 671800, an oral CRTH2 antagonist, as add on therapy in poorly controlled asthma patients prescribed an inhaled corticosteroidEur Respir J201240Suppl 563085
   Google Scholar
• SutherlandRTetzlaffKNivensCEfficacy and safety of BI 671800, an oral CRTH2 antagonist in controller naïve patients with poorly-controlled asthmaEur Respir J201240Suppl 563084
   Google Scholar
• MillerDWoodCBatemanEA randomized study of BI 671800, a CRTH2 antagonist, as add-on therapy in poorly controlled asthmaAllergy Asthma Proc20173815716428234053
   PubMed Web of Science ®Google Scholar
• CalbetMAndrésMArmengolCPharmacological characterization of CRTH2 antagonist LAS191859: long receptor residence time translates into long-lasting in vivo efficacyPharmacol Res201611120821627317944
   PubMed Web of Science ®Google Scholar
• SykesDABradleyMERiddyDMFevipiprant (QAW039), a slowly dissociating CRTH2 antagonist with the potential for improved clinical efficacyMol Pharmacol20168959360526916831
   PubMed Web of Science ®Google Scholar
• OtulanaBBowdenAYenYPuthukkerilSDevelopment of pitrakinra: an interleukin receptor antagonist to treat eosinophilic asthmaRespir Drug Deliv201212128
   Google Scholar
• PavordIDKornSHowarthPMepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trialLancet201238065165922901886
   PubMed Web of Science ®Google Scholar
• SzeflerSJPhillipsBRMartinezFDCharacterization of within-subject responses to fluticasone and montelukast in childhood asthmaJ Allergy Clin Immunol200511523324215696076
   PubMed Web of Science ®Google Scholar
• WoodruffPGModrekBChoyDFT-helper type 2-driven inflammation defines major subphenotypes of asthmaAm J Respir Crit Care Med200918038839519483109
   PubMed Web of Science ®Google Scholar
• BatemanEGuerrerosABrockhausFFevipiprant, an oral prostaglandin DP2 receptor (CRTH2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroidsEur Respir Med2017501700670
   PubMed Web of Science ®Google Scholar